MedTrace Logo

The Effect of Art Therapy on Physical and Psychological Symptoms of Breast Cancer Survivors

NCT02982421 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-12-05

No results posted yet for this study

Summary

Art Therapy is a health profession in which art making is utilized as a means of expression and communication within a therapeutic and supportive relationship \[1\]. Art therapy has been shown to reduce psychological (anxiety, negative mood) and physical (pain, fatigue) symptoms which accompany many breast cancer patients and survivors \[2-7\]. Qualitative studies provide an initial understanding of the mechanisms through which art therapy facilitates symptom reduction \[8\]. Breast cancer patients have reported that art therapy provided them with access to emotional material otherwise inaccessible \[9\]. The goal of this study is to examine the effect of art making within a therapeutic framework on emotional awareness and acceptance.

Conditions

Interventions

BEHAVIORAL

Group art therapy

Participants will engage in an art therapy group tailored at emotion expression related to the experience of breast cancer survivorship.

BEHAVIORAL

Control

Participants will receive Psychoeducational material in the form of a lecture and will engage in the coloring of mandalas.

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Rinat Yerushalmi, MD · Oncology Department, RMC

  • Tal Granot, MA, RN · Davidoff Cancer Center, RMC

  • Noga Sela, BA, RN · Oncology, RMC

  • Sylvia Drier, MA, RN · Davidoff Cancer Center, RMC

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-05-31
Completion
2017-06-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02982421 on ClinicalTrials.gov